Consistent with this observation, ApoBR3500Q heterozygotes had elevations of ApoB and ApoB:ApoA-1 that were strongly correlated with LDL-C, suggesting that in patients with FH, these biomarkers might be interchangeable with predicted CVD risk. The gene discussed is APOA1; the disease is familial hyperaldosteronism.